Why Is LEMAITRE VASCULAR IN (LMAT) Stock Moving Today?
LEMAITRE VASCULAR IN (LMAT) is drawing unusual attention today.
Why LMAT stock is down today
LeMaitre Vascular stock fell 15.28% to $89.62 in early trading on August 5, 2026. The decline followed the company’s Q2 2026 earnings report, which revealed earnings and revenue that fell short of estimates. The stock opened with a 12.1% gap down from the prior close and continued to decline through the session. The move reflects investor reaction to the company’s reduced guidance and supply chain challenges.
What Happened
LeMaitre Vascular reported Q2 2026 results that included GAAP earnings per share of $0.74, below the $0.79 estimate. Revenue came in at $70.382 million, missing the $70.973 million forecast. The company cited FX pressures, export delays, and supply risks as factors behind the underperformance. In response, LeMaitre lowered its full-year 2026 guidance. The company reduced GAAP EPS guidance from $2.93, $3.08 to $2.84, $2.94 and cut revenue guidance from $277.000 million, $283.000 million to $274.300 million, $278.300 million. The Artegraft product line, which now accounts for 21% of revenue, continues to drive growth, but the near-term challenges have dampened investor sentiment.
What The Data Shows
The stock opened at $93.00, a 12.1% gap down from the previous close of $105.78. It reached a session low of $85.85 before closing the session at $89.62. The volume of 0.1 million shares was 0.3 times the 3-month average. LeMaitre has a market cap of $2.4 billion and a P/E ratio of 38.9. The company’s trailing twelve-month revenue grew by 13.3%, and its net margin stands at 24.3%. Recent insider transactions include four sales totaling $6.3 million over the past 90 days, with the most recent filing on May 11, 2026.
What To Watch
LeMaitre Vascular is scheduled to release its Q3 2026 earnings report in the coming months. Investors will be watching for further clarity on the company’s ability to navigate supply chain issues and execute on its Artegraft expansion. Coverage of the stock remains active, with five stories published in the last 36 hours.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
LMAT by the numbers
The headlines behind the move
No wire coverage in the public window yet. Open the live terminal for the real-time tape.
More moves explained today
- Why is ABCL up today (+34.78%)
- Why is OBX up today (+27.27%)
- Why is NESR up today (+23.33%)
- Why is FSLY up today (+20.86%)
- Why is BTDR down today (-20.08%)
- Why is BSP up today (+15.70%)
More on LMAT: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier LMAT move explainers: 2026-08-05